INHA and pancreatic neuroendocrine tumor: Other tumor entities which can show high-level INHA expression include, for example, neuroendocrine tumors of the pancreas, cholangiocarcinoma, adenocarcinoma of the lung, gastric adenocarcinoma, and clear cell renal cell carcinoma.